Skip to content
thestock.space

As of 6 Nov 2026, GKB Ophthalmics trades at 9.3× trailing earnings, below the industry P/E of 28.6×, and the shares are 33% below their 52-week high. It earns ROCE of 8.1% and ROE of 2.3%, and sales grew 26% a year over 3 years. Debt is 0.21× equity. It is a small-cap company with a market cap of ₹30 Cr, ranked 10th of 11 Medical Instruments & Supplies companies by market cap; the shares fell 33% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹64.45
Day high
₹64.45
Day low
₹59.32
Prev. close
₹60.62
Volume
1.9K

Health check

2 good · 1 fair · 3 to check
  • ReturnsBehind

    −32.6% over a year, better than 1 of 7 peers.

  • Price tagCheaper

    P/E 9.3 vs industry 28.6.

  • GrowthStrong

    Sales +25.5% a year over 3 years.

  • ProfitabilityWeak

    ROCE 8.1% vs peer median 11.5%.

  • Balance sheetFair

    Debt 0.21× equity, interest covered 2.7×, Piotroski 5 of 9.

  • Red flags2 to check

    Return on equity is low at 2.3%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Instruments & Supplies

10 listed peers. Screen the industry

Small cap

₹30 Cr, #10 of 11 in its industry by size.

Defensive

Beta 0.48 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹150 Cr · profit ₹3 Cr
Market cap
₹30 Cr
Small cap
P/E
9.3
Industry 28.6
Price to book
0.57
Peers 5.26
Dividend yield
0.00%
ROE
2.3%
Peers 10.5%
ROCE
8.1%
Peers 11.5%
Debt to equity
0.21
Debt ₹12 Cr
EPS (TTM)
₹6.43
Face value ₹10
OPM (TTM)
6.3%
Net margin 2.2%
Sales growth
+2.3%
Latest quarter vs a year ago
Profit growth
n/a
Year-ago quarter not reported
Price to sales
0.20
EV/EBITDA 3.7

Strengths and risks

Strengths

  • P/E of 9.3 against an industry P/E of 28.6.

Risks to check

  • Return on equity is low at 2.3%.
  • 33% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About GKB Ophthalmics

GKB Ophthalmics Limited engages in the manufacture and sale of unfinished ophthalmic lenses in India and internationally. It offers semifinished organic lenses, such as single vision, bifocal, and progressive. The company was incorporated in 1981 and is based in Mapusa, India.

Headquarters
Mapusa
Employees
156
Sector
Healthcare
ISIN
INE265D01015
Website
gkb.net

Price range

52 weeks

₹55.01₹88.40

Today

₹59.32₹64.45
Avg volume (3M)
5.1K
1-year return
minus 32.6%
From 52-week high
minus 32.6%

Peers · Medical Instruments & Supplies

Compare with peersScreen the whole industry
Company
LENSKARTLenskart Solutions724.75plus 0.89%1,25,562160.713.487.2%6.7%20.8%––0.00%plus 79.8%
AGARWALEYEDr. Agarwal's Health Care516.35plus 0.91%16,37394.17.669.7%6.8%15.0%26.9%12.3%0.00%minus 0.7%
POLYMEDPoly Medicure1,612.30plus 0.63%16,34351.45.2613.3%11.0%15.2%18.8%21.6%0.22%minus 18.1%
TARSONSTarsons Products316.95minus 0.46%1,686151.72.644.8%2.3%−0.9%14.3%−43.8%0.00%plus 10.9%
LAXMIDENTLLaxmi Dental196.42minus 0.05%1,08134.84.4411.5%12.8%16.4%19.5%–0.00%minus 37.9%
PREVESTPrevest Denpro397.85minus 3.85%47822.03.8321.9%17.8%34.8%12.4%9.3%0.25%minus 21.2%
QMSMEDIQMS Medical Allied Services168.66minus 0.69%32628.65.6818.4%10.5%12.0%18.4%16.7%0.30%plus 75.0%
GKBGKB Ophthalmics59.56minus 1.75%309.30.578.1%2.3%6.8%25.5%–0.00%minus 32.6%
Median of 7 peers–−0.05%1,68651.45.2611.5%10.5%15.2%18.6%12.3%0.00%−0.7%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
32.330.256.829.833
31.527.155.427.430.3
0.831.42.42.7
2.5%10.1%2.4%8.0%8.2%
0.20.30.91.50.7
0.80.70.70.50.5
0.80.80.80.80.8
–––−1.5–
−0.61.90.71.12
−13.7%3.8%−4.4%−4.0%9.7%
−11.60.40.21
-2.023.170.880.382.00

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+25.5%
ROE
2.3%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
75.488.3109149
–+17.1%+23.5%+36.8%
71.787.7112140
3.70.6−2.68.6
4.9%0.7%−2.4%5.8%
0.50.90.50.5
1.31.41.61.8
2.82.93.13.2
0.100−0.9
0.1−2.8−6.73.1
16.6%−7.4%−5.2%2.5%
−0.2−2.8−71.2
-0.33-5.58-13.982.42

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
5555
57.754.74747.8
11.211.514.511.7
38.243.258.767.7
112115125132
23.922.12118.8
4.93.944
0000
14.117.212.94.4
69.171.387.2105
112115125132

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−2.84.2−3.4−3.8
1.4−1.72.59
−2.2−1.60.7−5.5
−3.50.9−0.2−0.4
−1.2−2.1−2.1−1
−42.1−5.6−4.8
−0–––

Shareholding pattern

Source: NSE filings

NSE hasn’t returned a shareholding pattern for this company.

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you